Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

JAK inhibitors offer new hope for treating severe alopecia areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

Clascoterone may be a promising treatment for hair loss.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.